Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelin and myocardial ischemia

D Hasdai1, R Kornowski, A Battler

  • 1Neufeld Cardiac Research Institute, Sackler Faculty of Medicine, Tel-Aviv University, Sheba Medical Center, Tel Hashomer, Israel.

Cardiovascular Drugs and Therapy
|August 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.

Cardiovascular diabetology·2020
Same author

Angiogram based fractional flow reserve in patients with dual/triple vessel coronary artery disease.

International journal of cardiology·2019
Same author

Peptide Binding Glucose Regulated Protein 78 Improves Type 1 Diabetes by Preventing Pancreatic β Cell Apoptosis.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2016
Same author

Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2015
Same author

Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study).

Cardiovascular drugs and therapy·2015
Same author

The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015

Endothelin, a vasoconstrictor, impacts the heart. Blocking endothelin action may reduce myocardial damage in ischemia and infarction, warranting further research into this interaction.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology

Background:

  • Endothelin is a potent vasoconstrictor affecting cardiac function.
  • Elevated endothelin levels are observed in myocardial ischemia, infarction, and angina.
  • The precise role of endothelin in myocardial ischemia remains incompletely understood.

Purpose of the Study:

  • To review current literature on endothelin's interaction with myocardial ischemia.
  • To explore the significance of endothelin in various ischemic heart conditions.

Main Methods:

  • Literature review of experimental and human studies.
  • Analysis of research on endothelin's effects in myocardial ischemia models.
  • Examination of studies investigating endothelin antagonists.

Related Experiment Videos

Main Results:

  • Endothelin levels are altered in myocardial ischemia and infarction.
  • Administration of endothelin-blocking agents reduced myocardial damage in experimental infarction models.

Conclusions:

  • Endothelin plays a significant role in myocardial ischemia.
  • Targeting endothelin pathways presents a potential therapeutic strategy for ischemic heart disease.